BioSpace News Archive

With $65 Million in Hand, Chinook Therapeutics Launches to Tackle Kidney Disease

The new company, which was founded earlier this year, will take a similar approach to treat kidney disease that oncologists have taken with cancer.

August 23, 2019
·
3 min read
·
Alex Keown
Combination Drug Shows Efficacy in Tough-to-Treat Blood Cancer

Researchers from Mount Sinai conducted a study of selinexor with dexamethasone in patients with multiple myeloma who have not responded to previous treatments and the results were quite promising.

August 23, 2019
·
3 min read
·
Alex Keown
Policy

Eli Lilly Wins Arbitration Hearing Against Adocia

Eli Lilly won an arbitration hearing over accusations the Indianapolis-based company misused confidential information regarding the intellectual property of its former business partner, France-based Adocia S.A.

August 23, 2019
·
2 min read
·
Alex Keown
Pharm Country

BeyondSpring’s Plinabulin Holds its Own in Quality of Life Study

In a head-to-head study, BeyondSpring’s plinabulin stood up to Amgen’s Neulasta (pegfilgrastim) in a quality of life study to prevent neutropenia, a common side effect for chemotherapy patients.

August 23, 2019
·
2 min read
·
Alex Keown
BioForest

In Wake of Terminations, Pharma Leaders Decry Actions That Will Limit Collaborations with Foreign Scientists

Leaders from across the pharmaceutical industry are decrying negative actions taken by government agencies and universities against Chinese researchers in the United States.

August 23, 2019
·
3 min read
·
Alex Keown